Researchers @itbofficial @Cambridge_Uni propose a structure-based methodology for identifying #ligands that activate the adenosine A2A receptor while simultaneously inhibiting the phosphodiesterase 10A #cancer. https://t.co/wsCBa0Lz31 #ITBresearch https:/
RT @UnivCamPharm: Recent publications from @AstraZeneca PhD students include @LauraItzhaki (Rohan Eapen), @GpcrL (@abi_pearce96 & Sabrina C…
Recent publications from @AstraZeneca PhD students include @LauraItzhaki (Rohan Eapen), @GpcrL (@abi_pearce96 & Sabrina Carvalho) & @psalmotoxin /Bulmer (Katie Barker) groups https://t.co/mm1QmZNmI3 https://t.co/DorQZXTMug https://t.co/IO36rtMR2l
new: "Structure‐based identification of dual ligands at the A2AR and PDE10A with anti‐proliferative effects in lung cancer cell‐lines" https://t.co/mMFd1jefjJ https://t.co/Ob173kcVUX